Details of the Drug

General Information of Drug (ID: DMT6H3J)

Drug Name
AbGn-168
Synonyms AbGn-168H; Antibody 168 (autoimmune diseases), Boehringer Ingelheim/AbGenomics; Anti-CD162 mAb (psoriasis), Boehringer/AbGenomics
Indication
Disease Entry ICD 11 Status REF
Allergy 4A80-4A85 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D02YIP

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
P-selectin glycoprotein ligand 1 (SELPLG) TTS5K8U SELPL_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01855880) Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Avarx.